SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-20-024776
Filing Date
2020-09-01
Accepted
2020-09-01 16:04:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM SCHEDULE 13D ea126290-sc13da2hakim_elite.htm SC 13D/A 47831
  Complete submission text file 0001213900-20-024776.txt   49183
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Subject) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-59693 | Film No.: 201154505
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ELITE PHARMACEUTICALS, INC. 165 LUDLOW AVE. NORTHVALE NJ 07647
Business Address
Hakim Nasrat A (Filed by) CIK: 0001583742 (see all company filings)

Type: SC 13D/A